Radio and PodcastLive Radio & Podcasts
Science & Medicine
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
BUFFALO, NY – June 15, 2026 – A new paper was in Volume 17 of Oncotarget on June 5, 2026, titled “A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepC...
Related Episodes
Continue listening to more episodes from Oncotarget.
Tumor-Infiltrating Lymphocyte Therapy Offers a Promising Approach for Treating Solid Tumors
Aug 31, 2026 - 00:04:20
KRAS G12C Mutation Identified as a Rare Potential Target in Genitourinary Cancers
Aug 28, 2026 - 00:04:29
New Analysis Challenges Methods Used to Measure Residual DNA in mRNA Vaccines
Aug 25, 2026 - 00:06:37
Trk and IGF1R-Related Signaling Linked to Delayed Ewing Sarcoma Growth
Aug 10, 2026 - 00:06:50
CTHRC1 in the Tumor Microenvironment Drives Colorectal Cancer Growth in Mouse Study
Aug 10, 2026 - 00:09:03
Artificial Intelligence Could Transform Nutrition Care for Cancer Patients
Jul 28, 2026 - 00:08:41